Oncotelic Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
OTLC Over the counter 8731 https://www.oncotelic.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Oncotelic Therapeutics Inc

Linkage of Cancer and Lupus in Gliomas Patients - Mar 25th, 2024 12:10 pm
Invitation to Participate in STOP-PC Clinical Trial - Mar 4th, 2024 1:17 pm
Oncotelic Therapeutics Announces Clinical Linkage of TGFB2 and IFNGR2 in Pediatric DMG Patients - Jan 16th, 2024 1:00 pm
Oncotelic Therapeutics Announces Opening of GMP Manufacturing Plant - Dec 18th, 2023 1:10 pm
Oncotelic Therapeutics Announces CEO To Discuss Proprietary AI Technology at Ibero-American Chatbot Summit. - Nov 28th, 2023 12:10 pm
Oncotelic Reports Q3 2023 Compared to Q3 2022 Financial Results - Nov 15th, 2023 2:00 pm
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023 - Aug 25th, 2023 11:00 am
Sapu BioScience and Cromos Pharma initiating P201 – A Registrational trial for OT-101 in Pancreatic Cancer - Aug 23rd, 2023 11:10 am
Oncotelic Launches PR Chatbot - Jun 12th, 2023 12:10 pm
Oncotelic Participating at 2023 BIO International Convention - May 16th, 2023 12:00 pm
Oncotelic Launches PDAO SEC Chatbot - Apr 24th, 2023 11:30 am